Email UpdatesThis letter announces details on Congress's elimination of the X-waiver (DATA-Waiver) to increase buprenorphine accessibility in the Consolidated Appropriations Act of 2023, increasing accessibility of medication-assisted treatment (MAT).
Source
Drug Enforcement Administration (DEA)
File Size
148 KB
Year
Format
Terms of Use
Topic
Resource Type
Special Collection